CHCT Q3: Net Income $3.1M, FFO $0.54/Share, $31.4M Ohio Sale Closed in October
CHCT is trading near its 52-week low of $12.58 (5.8% above the low).
Summary
CHCT reported Q3 net income of $3.1M ($0.09/share) and FFO of $0.54 per share, with $558.4M of debt, only $116.0M of revolver capacity left, and a $31.4M Ohio property sale closing in October.
Key Events · Earnings and Guidance · CHCT
-
Q3 Earnings Improve Year Over Year
Net income was $3.068M ($0.09 per diluted share) versus $1.640M ($0.03) a year ago; nine-month net income swung to $7.980M from a $9.326M loss.
-
FFO $0.54, AFFO $0.58 Per Share
FFO rose to $14.960M for the quarter from $13.547M, and AFFO to $16.017M from $15.099M, helped by lower stock-based compensation.
-
Leverage and Floating-Rate Exposure
Debt totals $558.382M, including $284.0M drawn on the revolver with $116.0M of capacity left; $75M of swaps matured March 29, 2026 unreplaced, pushing quarterly interest expense up 6.2% to $7.515M.
-
Ohio Sale to Add ~$9.1M Q4 Gain
An Ohio inpatient rehabilitation facility sold October 15, 2026 for about $31.4M net proceeds, with the gain expected in the fourth quarter and proceeds earmarked for like-kind exchange acquisitions.
Analysis · CHCT · Real Estate & Construction
The quarter is solid but not transformative: net income of $3.1M ($0.09 per share) versus $1.6M a year ago, with FFO at $0.54 per diluted share and AFFO at $0.58. The balance sheet behind those numbers matters more. Cash sits at just $1.35M against $558.4M of debt, and the $284.0M drawn on the revolver leaves only $116.0M of capacity. Because the $75M of swaps that matured in March 2026 were not replaced, that slice now floats near 5.6%, and interest expense rose 6.2% year over year to $7.5M for the quarter. Capital recycling is the offset: the Ohio inpatient rehab facility sold October 15 for $31.4M net with a ~$9.1M gain expected in Q4, and four properties under contract for roughly $99.0M give the company something to redeploy into. The $300.0M ATM remains completely undrawn, the main dilution lever if the acquisition pipeline needs equity.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHCT was trading at $13.31 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $374.2M. The 52-week trading range was $12.58 to $19.17. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.